BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3270 related articles for article (PubMed ID: 7274625)

  • 1. Some chemotherapeutic properties of two new antitumor antibiotics, saframycins A and C.
    Arai T; Takahashi K; Ishiguro K; Mikami Y
    Gan; 1980 Dec; 71(6):790-6. PubMed ID: 7274625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saframycin S, a new saframycin group antibiotic.
    Mikami Y; Yokoyama K; Tabeta H; Nakagaki K; Arai T
    J Pharmacobiodyn; 1981 Apr; 4(4):282-6. PubMed ID: 7264873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Discovery and development of unknown potentialities of microorganisms with special reference to saframycin group antitumor antibiotics].
    Arai T
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2617-24. PubMed ID: 6508318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.
    Fujimoto S; Ogawa M
    Cancer Chemother Pharmacol; 1982; 8(2):157-62. PubMed ID: 7105379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of new semisynthetic saframycin derivatives.
    Kaneda S; Hour-Young C; Yazawa K; Takahashi K; Mikami Y; Arai T
    Jpn J Cancer Res; 1986 Oct; 77(10):1043-9. PubMed ID: 3096920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
    Ishizeki S; Ohtsuka M; Irinoda K; Kukita K; Nagaoka K; Nakashima T
    J Antibiot (Tokyo); 1987 Jan; 40(1):60-5. PubMed ID: 3104267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of mitomycin C-dextran conjugate against various murine tumors.
    Hashida M; Kato A; Kojima T; Muranishi S; Sezaki H; Tanigawa N; Satomura K; Hikasa Y
    Gan; 1981 Apr; 72(2):226-34. PubMed ID: 6169584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of saframycins.
    Kishi K; Yazawa K; Takahashi K; Mikami Y; Arai T
    J Antibiot (Tokyo); 1984 Aug; 37(8):847-52. PubMed ID: 6480503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
    Tanaka N
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of spergualin, a novel antitumor antibiotic.
    Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
    Dawson KM
    Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumor and cytocidal activities of a newly isolated benzenoid ansamycin, macbecin I.
    Ono Y; Kozai Y; Ootsu K
    Gan; 1982 Dec; 73(6):938-44. PubMed ID: 6186564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of safracins A and B, heterocyclic quinone antibiotics, on experimental tumors in mice.
    Okumoto T; Kawana M; Nakamura I; Ikeda Y; Isagai K
    J Antibiot (Tokyo); 1985 Jun; 38(6):767-71. PubMed ID: 4019320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor activity of macromomycin].
    Kato T; Yamanaka N; Katayama S; Mizutani M; Ota K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1097-101. PubMed ID: 7184442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental antitumor activity of BMY-28090, a new antitumor antibiotic.
    Schurig JE; Bradner WT; Basler GA; Rose WC
    Invest New Drugs; 1989 Jul; 7(2-3):173-8. PubMed ID: 2793369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activities of (2"R)-4'-O-tetrahydropyranyl-adriamycin (THP) and its combination with other antitumor agents on murine tumors.
    Matsushita Y; Kumagai H; Yoshimoto A; Tone H; Ishikura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1985 Oct; 38(10):1408-19. PubMed ID: 4066493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of a new fluoropyrimidine derivative, 5'-deoxy-5-fluorouridine, against murine and human experimental tumors.
    Fujimoto S; Wang Y; Inoue K; Ogawa M
    Jpn J Cancer Res; 1985 Jul; 76(7):644-50. PubMed ID: 3161854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of mouse tumors with 7-con-O-methylnogarol and other analogs of the anthracycline antibiotic, nogalamycin.
    Neil GL; Kuentzel SL; McGovren JP
    Cancer Treat Rep; 1979; 63(11-12):1971-8. PubMed ID: 526931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 164.